ZimVie (ZIMV) Competitors

MiMedx Group (NASDAQ:MDXG) and ZimVie (NASDAQ:ZIMV) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations, media sentiment, community ranking and dividends.

Do analysts rate MDXG or ZIMV?

MiMedx Group currently has a consensus target price of $12.50, suggesting a potential upside of 94.70%. ZimVie has a consensus target price of $16.33, suggesting a potential upside of 71.39%. Given MiMedx Group's stronger consensus rating and higher possible upside, equities research analysts plainly believe MiMedx Group is more favorable than ZimVie.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiMedx Group	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
ZimVie	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.67

Do insiders & institutionals believe in MDXG or ZIMV?

79.2% of MiMedx Group shares are owned by institutional investors. Comparatively, 95.6% of ZimVie shares are owned by institutional investors. 1.7% of MiMedx Group shares are owned by company insiders. Comparatively, 3.0% of ZimVie shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Does the MarketBeat Community believe in MDXG or ZIMV?

MiMedx Group received 46 more outperform votes than ZimVie when rated by MarketBeat users. Likewise, 83.87% of users gave MiMedx Group an outperform vote while only 27.27% of users gave ZimVie an outperform vote.

Company	Underperform	Outperform
MiMedx Group	Outperform Votes 52 83.87%	Underperform Votes 10 16.13%
ZimVie	Outperform Votes 6 27.27%	Underperform Votes 16 72.73%

Does the media refer more to MDXG or ZIMV?

In the previous week, MiMedx Group had 7 more articles in the media than ZimVie. MarketBeat recorded 10 mentions for MiMedx Group and 3 mentions for ZimVie. MiMedx Group's average media sentiment score of 1.49 beat ZimVie's score of 1.35 indicating that MiMedx Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiMedx Group	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ZimVie	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is MDXG or ZIMV more profitable?

MiMedx Group has a net margin of 23.86% compared to ZimVie's net margin of -77.31%. MiMedx Group's return on equity of 26.21% beat ZimVie's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiMedx Group	23.86%	26.21%	18.15%
ZimVie	-77.31%	2.90%	1.17%

Which has preferable earnings and valuation, MDXG or ZIMV?

MiMedx Group has higher earnings, but lower revenue than ZimVie. ZimVie is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiMedx Group	$352.38M	2.69	$58.23M	$0.27	23.78
ZimVie	$443.55M	0.60	-$393.28M	-$0.71	-13.42

Which has more volatility and risk, MDXG or ZIMV?

MiMedx Group has a beta of 1.82, suggesting that its stock price is 82% more volatile than the S&P 500. Comparatively, ZimVie has a beta of 2.1, suggesting that its stock price is 110% more volatile than the S&P 500.

Summary

MiMedx Group beats ZimVie on 14 of the 19 factors compared between the two stocks.